|
|
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
|
|
|
(Address of Principal Executive Offices)
|
(Zip Code)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
Item 1.01. |
Entry into a Material Definitive Agreement.
|
Item 2.03. |
Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of the Registrant.
|
Item 9.01 |
Financial Statements and Exhibits.
|
(d) |
Exhibits:
|
Amendment No. 4 to Credit and Security Agreement, dated as of February 20, 204, among STRATA Skin Sciences, Inc., MidCap Financial Trust,
as administrative agent, and the lenders identified therein.
|
|
Amendment No. 3 to Credit and Security Agreement, dated as of June 30, 2023, among STRATA Skin Sciences, Inc., MidCap Financial Trust, as
administrative agent, and the lenders identified therein (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on June 30, 2023).
|
|
Credit and Security Agreement, dated as of September 30, 2021, as amended January 10, 2022, September 6, 2022 and June 30, 2023, among
STRATA Skin Sciences, Inc., MidCap Financial Trust, as administrative agent, and the lenders identified therein (incorporated by reference to Exhibit A to Exhibit 10.2).
|
|
Letter agreement, dated as of February 20, 2024, between STRATA Skin Sciences, Inc. and MidCap Financial Trust, as administrative agent.
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document).
|
|
|
*
|
Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish a copy of
such schedules and exhibits, or any section thereof, to the SEC upon request.
|
STRATA SKIN SCIENCES, INC.
|
|||
Date: February 21, 2024
|
By:
|
/s/ Christopher Lesovitz
|
|
Christopher Lesovitz
|
|||
Chief Financial Officer
|
AGENT:
|
MIDCAP FINANCIAL TRUST
|
||
By:
|
Apollo Capital Management, L.P.,
its investment manager
|
||
By:
|
Apollo Capital Management GP, LLC,
its general partner
|
||
By:
|
/s/ Maurice Amsellem | ||
Name:
|
Maurice Amsellem
|
||
Title:
|
Authorized Signatory
|
LENDERS:
|
MIDCAP FINANCIAL TRUST
|
||
By:
|
Apollo Capital Management, L.P.,
its investment manager
|
||
By:
|
Apollo Capital Management GP, LLC,
its general partner
|
||
By:
|
/s/ Maurice Amsellem | ||
Name:
|
Maurice Amsellem
|
||
Title:
|
Authorized Signatory
|
LENDERS:
|
MIDCAP FUNDING XLIX TRUST
|
||
By:
|
Apollo Capital Management, L.P.,
its investment manager
|
||
By:
|
Apollo Capital Management GP, LLC,
its general partner
|
||
By:
|
/s/ Maurice Amsellem | ||
Name:
|
Maurice Amsellem
|
||
Title:
|
Authorized Signatory
|
LENDERS: |
ELM 2020-3 TRUST
|
||
|
|
||
|
By: |
MidCap Financial Services Capital Management,
|
|
LLC, as Servicer | |||
|
|
||
|
By: | /s/ John O’Dea | |
|
Name: | John O’Dea | |
|
Title: | Authorized Signatory | |
|
|||
|
ELM 2020-4 TRUST | ||
By: |
MidCap Financial Services Capital Management,
|
||
LLC, as Servicer | |||
|
By: | /s/ John O’Dea | |
Name: | John O’Dea | ||
Title: | Authorized Signatory |
STRATA SKIN SCIENCES, INC. |
|
By: |
|
Name: |
|
Title: |
|
Defined Period Ending
|
Minimum Net Revenue
|
|||
September 30, 2021
|
$
|
24,000,000.00
|
||
December 31, 2021
|
$
|
25,000,000.00
|
||
March 31, 2022
|
$
|
25,500,000.00
|
||
June 30, 2022
|
$
|
26,000,000.00
|
||
September 30, 2022
|
$
|
27,000,000.00
|
||
December 31, 2022
|
$
|
28,000,000.00
|
||
March 31, 2023
|
$
|
28,500,000.00
|
||
June 30, 2023
|
$
|
29,000,000.00
|
||
September 30, 2023
|
$
|
33,000,000.00
|
||
December 31, 2023
|
$
|
36,000,000.00
|
||
March 31, 2024
|
$
|
29,000,000.00
|
||
June 30, 2024
|
$
|
29,250,000.00
|
||
September 30, 2024
|
$
|
29,500,000.00
|
||
December 31, 2024
|
$
|
30,000,000.00
|
||
March 31, 2025
|
$
|
30,500,000.00
|
||
June 30, 2025
|
$
|
31,000,000.00
|
||
September 30, 2025
|
$
|
31,500,000.00
|
||
December 31, 2025
|
$
|
32,000,000.00
|
||
March 31, 2026
|
$
|
32,250,000.00
|
||
June 30, 2026
|
$
|
32,500,000.00
|
||
September 30, 2026
|
$
|
32,750,000.00
|
||
December 31, 2026
|
$
|
33,000,000.00
|
|
|
c/o MidCap Financial Services, LLC, as servicer | |
7255 Woodmont Avenue, Suite 300 | |
Bethesda, Maryland 20814 | |
www.midcapfinancial.com |
Re:
|
Amendment No. 4 to Credit and Security Agreement with STRATA Skin Sciences, Inc.
|
1. |
on the Closing Date, Borrower paid to Agent for the ratable benefit of the Lenders committed to make Credit Extensions as of the Closing Date, in accordance with their respective Pro
Rata Shares, an origination fee in an amount equal to $40,000. Such fee was fully earned as of the Closing Date.
|
2. |
on the Maturity Date, or on any earlier date on which the Obligations become due and payable in full (whether by voluntary prepayment by Borrower, by mandatory prepayment by
Borrower, by reason of the occurrence of an Event of Default or the acceleration (including any automatic acceleration due to the occurrence of an Event of Default described in Section 10.1(f) of the Credit Agreement) or otherwise) or are
otherwise paid in full (such date, the “Full Exit Fee Payment Date”), Borrower shall pay to Agent, for the benefit of all Lenders in accordance with
their respective Pro Rata Shares, an amount equal to (a) four percent (4.00%) of the Exit Fee Base Amount (as defined below) less (b) any Partial Exit
Fee (as defined below) previously paid. The “Exit Fee Base Amount” means the total aggregate principal amount of Credit Extensions made pursuant to the
Credit Agreement (regardless of any repayment or prepayment thereof) as of the Full Exit Fee Payment Date.
|
3. |
on the date of any voluntary or mandatory partial prepayment of the Credit Facilities (or, in the case of a mandatory partial prepayment under the Credit Agreement, on the date such
mandatory prepayment becomes due and payable) (each such date, a “Partial Exit Fee Payment Date”), Borrower shall pay to Agent, for the benefit of all
Lenders in accordance with their respective Pro Rata Shares, an amount equal to four percent (4.00%) of the principal amount of the Credit Facilities paid or prepaid (or in the case of a mandatory prepayment, required to be paid) on such
Partial Exit Fee Payment Date (the fee in this paragraph 3 is herein referred to as the “Partial Exit Fee”).
|
4. |
On the Third Amendment Effective Date, Borrower paid to Agent, for the benefit of all Lenders committed to make Credit Extensions in respect of Credit Facility #2, an origination fee
in an amount equal to the Credit Extensions in respect of Credit Facility #2 multiplied by one half of one percent (0.50%). All fees payable pursuant
to this paragraph are paid and non-refundable
|
5. |
Contemporaneous with the funding of the Credit Extensions in respect of Credit Facility #3, Borrower shall pay to Agent, for the benefit of all Lenders committed to make Credit
Extensions in respect of Credit Facility #3, an origination fee in an amount equal to the Credit Extensions in respect of Credit Facility #3 multiplied by
one half of one percent (0.50%). All fees payable pursuant to this paragraph shall be due and payable on the date the Credit Extensions in respect of Credit Facility #3 are funded and, once paid, shall be non-refundable.
|
MIDCAP FINANCIAL TRUST,
|
|
as Agent for Lenders |
By: | Apollo Capital Management, L.P., | |
its investment manager | ||
|
||
By: |
Apollo Capital Management GP, LLC, | |
its general partner | ||
By: | /s/ Maurice Amsellem |
Name: | Maurice Amsellem | |
Its: | Authorized Signatory |
By: | /s/ Chris Lesovitz |
|
Name: | Chris Lesovitz |
|
Title: | CFO |
|